目的 探讨N端脑钠肽前体(NT-proBNP)在评估维持性血液透析患者容量状态中的临床应用价值.方法 选择非临床显性水肿的维持性血液透析患者145例为研究对象.采用生物电阻抗方法检测患者多余细胞外液(Overhydration,OH值),胶体金法检测血浆NT-proBNP水平.按△OH水平(△OH=OH值-体重增加量)将患者分为容量超负荷组(H组,90例)、干体重达标组(N组,36例)和低干体重组(L组,19例).同期检测患者透析前血压、体质量增加值、Hb、Alb、BUN、Scr等指标.调整H组患者干体重,观察3月内患者容量负荷变化对血浆NT-proBNP水平的影响.结果 (1)126例患者NT-proBNP基线水平均高于正常范围.H组NT-proBNP中位数[M(1/4,3/4)]为1318.50 (717.00,3154.25) pg/ml;N组为703.50(873.00,450.50) pg/ml.基线NT-proBNP水平与△OH值呈正相关(r=0.801,P< 0.001).(2)3月后H组患者OH值及NT-proBNP均较调整前明显下降.其中41例患者干体重达标(H1组),NT-proBNP中位值为685.00 (422.50,988.50) pg/ml,△OH(0.63±0.23)L;49例患者持续未达标(H2组),NT-proBNP中位值为1569.00 (982.50,2500.50) pg/ml,△OH (1.75±0.71)L.两组间△OH和NT-proBNP的比较差异有统计学意义(均P<0.05).△OH和NT-proBNP呈正相关(r=0.684,P< 0.001).(3)当以△OH绝对值≤1定义干体重达标时,NT-proBNP在判断患者容量状态的受试者工作曲线(ROC)下面积(AUC)为0.818,95%可信区间0.733~0.904 (P< 0.001).NT-proBNP判断维持性血液透析患者容量状态的最佳临界值为962.50pg/ml,诊断的灵敏度为79.6%,特异度为73.2%.结论 维持性血液透析患者NT-proBNP水平升高.临床非显性水肿患者血NT-proBNP水平升高提示容量增加,可作为早期干体重调整的临床指标.
objective To investigate the value of NT-proBNP in assessing the volume status in maintenance hemodialysis patients with non-dominant edema.Methods One hundred and forty-five patients were recruited.Bioimpedance measurements were performed for overhydration (OH).NT-proBNP was detected by colloidal gold method.Patients were divided into three groups by levels of OH variability (△ OH,equal to OH minus weight increase) as group H (hypervolemia,n=90); group N (normovolemia,n=36) and group L (hypovolemia,n=19).Hemoglobin,albumin,blood urea nitrogen and serum creatinine were assayed,blood pressure and body mass increase were recorded.Dry weight of patients in Group H were adjusted in 3 months,the relationship between NT-proBNP and volume change were assessed.Results (1) At baseline,overall plasma NT-proBNP levels were higher than normal range.The median NT-proBNP levels in group H and group N were [1318.50(IQR 717.00,3154.25) pg/ml] and [703.50 (IQR 873.00,450.50) pg/ml],respectively.NT-proBNP was positively correlated with △OH value (r=0.801,P < 0.001).(2) After 3 months,NT-proBNP levels in group H was significantly lower than baseline.Forty-one patients reached normal volume range (group H1),49 patients were resistant hypervolemia (group H2).The median NT-proBNP levels in group H1 and group H2 were [685.00 (IQR 422.50,988.50) pg/ml] and [1569.00 (IQR 982.50,2500.50) pg/ml],△ OH in group H1 and group H2 were [(0.63±0.23)L] and [(1.75±0.71)L],respectively.NT-proBNP and △ OH value in two groups had significant difference (P < 0.05).NT-proBNP was positively correlated with △ OH value (r=0.684,P < 0.001).(3) The area under ROC curve for NT-proBNP was 0.818,95%CI (0.733~ 0.904),P < 0.001,since the absolute value of normovolemia was defined as ≤ 1.The cut off value of plasma NT-proBNP was set at 962.50 pg/ml in MHD patients with non-dominant edema,the diagnostic specificity and sensitivity were 79.6% and 73.2%.Concl